{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:53:50Z","timestamp":1768006430191,"version":"3.49.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Hyperkalemia is a well-recognized electrolyte abnormality in patients with chronic kidney disease (CKD). Potassium binders are often used to prevent and treat hyperkalemia. However, few studies have evaluated the difference in serum potassium (K<jats:sup>+<\/jats:sup>) level-lowering effect during the post-acute phase between the novel potassium binder, sodium zirconium cyclosilicate (ZSC), and conventional agents. This retrospective study included patients who received potassium binders (either ZSC or calcium polystyrene sulfonate [CPS]) in our hospital between May 2020 and July 2022. The patients were divided into the ZSC and CPS groups. After propensity score matching, we compared changes from baseline to the first follow-up point, at least 4 weeks after initiating potassium binders, in electrolytes including K<jats:sup>+<\/jats:sup> level between the two groups. Of the 132 patients, ZSC and CPS were administered in 48 and 84 patients, respectively. After matching, 38 patients were allocated to each group. The ZSC group showed greater reduction in K<jats:sup>+<\/jats:sup> levels than did the CPS group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). Moreover, a significant increase in serum sodium minus chloride levels, a surrogate marker for metabolic acidosis, was observed in the ZSC group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). Our results demonstrated that ZSC could potentially improve hyperkalemia and metabolic acidosis in patients with CKD.<\/jats:p>","DOI":"10.3389\/fmed.2023.1137981","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T05:11:40Z","timestamp":1678079500000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Takashin","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiko","family":"Azegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohkichi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Monkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ckj\/sfab243","article-title":"How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies","volume":"15","author":"Humphrey","year":"2021","journal-title":"Clin Kidney J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"CD006257","DOI":"10.1002\/14651858.CD006257","article-title":"Craig JC: Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease","volume":"2006","author":"Strippoli","year":"2006","journal-title":"Cochrane Database Syst Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41440-018-0116-3","article-title":"Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Mishima","year":"2019","journal-title":"Hypertens Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction: a review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1186\/cc11872","article-title":"Severe hyperkalemia requiring hospitalization: predictors of mortality","volume":"16","author":"An","year":"2012","journal-title":"Crit Care."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.ekir.2019.05.018","article-title":"Hyperkalemia in real-world patients under continuous medical care in Japan","volume":"4","author":"Kashihara","year":"2019","journal-title":"Kidney Int Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000479802","article-title":"Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and\/or diabetes","volume":"46","author":"Collins","year":"2017","journal-title":"Am J Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.xkme.2020.09.003","article-title":"Clinical and economic burden of hyperkalemia: a nationwide hospital-based cohort study in Japan","volume":"2","author":"Kanda","year":"2020","journal-title":"Kidney Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/ndt\/gfx312","article-title":"Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes\u2014a Danish population-based cohort study","volume":"33","author":"Thomsen","year":"2018","journal-title":"Nephrol Dial Transplant."},{"key":"B10","first-page":"S1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl."},{"key":"B11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1053\/j.jrn.2020.08.007","article-title":"Knowledge does not correspond to adherence of renal diet restrictions in patients with chronic kidney disease stage 3-5","volume":"31","author":"Betz","year":"2021","journal-title":"J Ren Nutr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1681\/ASN.2010010079","article-title":"Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?","volume":"21","author":"Sterns","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"B13","first-page":"542","article-title":"Calcium polystyrene sulfonate-induced gastrointestinal tract necrosis and perforation","volume":"82","author":"Buraphat","year":"2019","journal-title":"Acta Gastroenterol Belg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ahj.2021.09.014","article-title":"Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes","volume":"243","author":"Xu","year":"2022","journal-title":"Am Heart J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/ckj\/sfac077","article-title":"Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors","volume":"15","author":"Ren","year":"2022","journal-title":"Clin Kidney J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"A28","DOI":"10.1093\/eurheartj\/suy035","article-title":"Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate","volume":"21","author":"Rosano","year":"2019","journal-title":"Eur Heart J Suppl."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e114686","DOI":"10.1371\/journal.pone.0114686","article-title":"Characterization of structure and function of ZS-9, a K+ selective Ion trap","volume":"9","author":"Stavros","year":"2014","journal-title":"PLoS ONE."},{"key":"B18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ehf2.12561","article-title":"Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo-controlled HARMONIZE-Global study","volume":"7","author":"Zannad","year":"2020","journal-title":"ESC Heart Fail."},{"key":"B19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","article-title":"Interpretation of serum calcium in patients with abnormal serum proteins","volume":"4","author":"Payne","year":"1973","journal-title":"Br Med J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1053\/j.ajkd.2016.12.019","article-title":"Sodium-chloride difference as a simple parameter for acid-base status assessment","volume":"69","author":"Havlin","year":"2017","journal-title":"Am J Kidney Dis."},{"key":"B22","unstructured":"Pharmaceuticals and Medical Devices Agency"},{"key":"B23","unstructured":""},{"key":"B24","doi-asserted-by":"publisher","first-page":"e81045","DOI":"10.1371\/journal.pone.0081045","article-title":"Optimal caliper width for propensity score matching of three treatment groups: a Monte Carlo study","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE."},{"key":"B25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1111\/jcpt.13766","article-title":"Hyperkalaemia and potassium binders: retrospective observational analysis looking at the efficacy and cost effectiveness of calcium polystyrene sulfonate and sodium zirconium cyclosilicate","volume":"47","author":"Huda","year":"2022","journal-title":"J Clin Pharm Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1523-1755.2002.00350.x","article-title":"Hyperkalemia: an adaptive response in chronic renal insufficiency","volume":"62","author":"Gennari","year":"2002","journal-title":"Kidney Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.mayocp.2013.06.005","article-title":"Sanders PW: Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence","volume":"88","author":"Aaron","year":"2013","journal-title":"Mayo Clin Proc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.xkme.2020.04.007","article-title":"Impact of dietary potassium restrictions in ckd on clinical outcomes: benefits of a plant-based diet","volume":"2","author":"Clegg","year":"2020","journal-title":"Kidney Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and Type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10157-017-1412-y","article-title":"Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia","volume":"22","author":"Nakayama","year":"2018","journal-title":"Clin Exp Nephrol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0173542","DOI":"10.1371\/journal.pone.0173542","article-title":"Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients","volume":"12","author":"Yu","year":"2017","journal-title":"PLoS ONE."},{"key":"B35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF01956159","article-title":"Reduction of potassium in drinks by pre-treatment with calcium polystyrene sulphonate","volume":"152","author":"Schr\u00f6der","year":"1993","journal-title":"Eur J Pediatr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1159\/000516371","article-title":"Metabolic acidosis in patients with CKD: epidemiology, pathogenesis, and treatment","volume":"7","author":"Adamczak","year":"2021","journal-title":"Kidney Dis (Basel)."},{"key":"B37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1159\/000523911","article-title":"Effect of sodium zirconium cyclosilicate on serum potassium and bicarbonate in patients with hyperkalemia and metabolic acidosis associated with chronic kidney disease: rationale and design of the NEUTRALIZE study","volume":"146","author":"Ash","year":"2022","journal-title":"Nephron."},{"key":"B38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1159\/000504078","article-title":"Efficacy and safety of sodium zirconium cyclosilicate for treatment of hyperkalemia: an 11-month open-label extension of HARMONIZE","volume":"50","author":"Roger","year":"2019","journal-title":"Am J Nephrol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.mayocp.2019.05.019","article-title":"Potassium binders for hyperkalemia in chronic kidney disease-diet, renin-angiotensin-aldosterone system inhibitor therapy, and hemodialysis","volume":"95","author":"Palmer","year":"2020","journal-title":"Mayo Clin Proc."},{"key":"B40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12882-022-02903-7","volume":"23","author":"Kim","year":"2022","journal-title":"BMC Nephrol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1137981\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T05:11:45Z","timestamp":1678079505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1137981\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":40,"alternative-id":["10.3389\/fmed.2023.1137981"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1137981","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"article-number":"1137981"}}